Here's something I whipped up this morning, still need to verify a few inputs. From a valuation perspective, things are looking good.
For any of the long term holders here, I'd be interested to hear the rational for why they switched from providing the ACMR in their updates, to a standard revenue value? Any ideas?
Note: Fair Value ARR Multiple factors in the ARR Growth, TAM and Profitability. In this case, the current ARR Multiple is sitting around 10x which is fairly conservative. With their current growth, an ARR of ~15x would be reasonable. In contrast Pro Medicus, a much beloved SaaS business is trading on a ARR multiple of nearly 50x with a measly CAGR of 22%. Apologies to anyone that holds that stonk
Lastly thanks to my #1 fan @Herpzanederp for all of the support and advice he gives me
DYOR cobbas, this could just be a ponzi scheme idk.
- Forums
- ASX - By Stock
- PPH
- Pushpay SaaS Valuation
Pushpay SaaS Valuation
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online